News And Announcements
DS Smith to buy Romanian packaging and paper group for EUR208m
DS Smith has agreed to buy Romanian integrated packaging and paper group EcoPack and EcoPaper for an enterprise value of around €208m in a deal that is expected to be immediately enhancing to earnings.
BHP Billiton copper output drops but FY guidance unchanged
BHP Billiton posted a decline in iron ore production in the three months to the end of September, but said it remains on track to meet production targets for the year.
Rio Tinto settles with FCA over Mozambique impairment, faces US fraud claims
Rio Tinto was slapped with a £27. 4m fine by the City watchdog for failings in its financial reporting process relating to the disastrous $3. 7bn purchase of coal mining assets in Mozambique, an issue that US regulators have also now begun to investigate.
IP Group takeover of Touchstone goes unconditional
IP Group updated the market again on its takeover offer for Touchstone Innovations on Wednesday, confirming that as at 1300 BST on Tuesday, it had received valid acceptances of its offer in respect of 155,859,312 Touchstone shares, representing 96. 6844% of Touchstone’s issued share capital.
Nostrum flags delay to GTU3 completion
Independent oil and gas company Nostrum Oil & Gas updated the market on the progress of GTU3 on Wednesday, reporting that due to the delayed delivery of some specially designed valves required for the tie-in of GTU3 with GTU1 and GTU2, it would not be possible to bring gas into GTU3 in 2017.
Reckitt Benckiser cuts full year guidance, makes further pharma provision
After bearing the brunt of a "soft" third quarter Reckitt Benckiser has downgraded its full year guidance, with the Vanish-to-Durex maker confident that it can overcome the continued challenging market.
Rathbone Brothers funds under management rise in third quarter
FTSE 250 wealth manager Rathbone Brothers reported a jump in assets in the third quarter on Wednesday as inflows grew.
Spectris completes acquisition of Omnicon
Spectris has completed the acquisition of privately-held US company The Omnicon Group, for an initial consideration of $29m.
AstraZeneca granted priority review from FDA for Lynparza in metastatic breast cancer
AstraZeneca said on Wednesday that it and Merck & Co have been granted priority review by the US Food and Drug Administration for a supplemental new drug application for the use of Lynparza (olaparib) tablets in patients with metastatic breast cancer who have been previously treated with chemotherapy.